Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NY-ESO SPEAR
NY-ESO SPEAR
After setback, Adaptimmune revamps T cell study
BioPharma Dive
Thu, 10/13/16 - 10:53 am
Adaptimmune
t cell therapy
NY-ESO SPEAR
ovarian cancer